NOV 13, 2019 9:31 AM PST

Sherlock's DNA biosensors set to make diagnostics elementary

WRITTEN BY: Tara Fernandez

Waiting anxiously to receive results from expensive diagnostic laboratory tests could soon be a thing of the past thanks to a technological breakthrough. Engineering start-up Sherlock Biosciences, in collaboration with UK diagnostics company Mologic, recently announced they are joining forces to develop sophisticated molecular diagnostic devices simple enough for anyone to use - all from the comfort of home.

Backed by funding from the Bill & Melinda Gates Foundation, this new venture aims to blend Sherlock’s proprietary synthetic biology-based platform with Mologic’s lateral flow immunoassays. The result? Easy-to-use diagnostic devices, completely bypassing the need for complicated instrumentation and expert technicians.

Lateral flow technology is already widely used for point-of-care testing, with the most common example being pregnancy test sticks. Biological samples applied to the device get drawn up through a membrane and flow over antibodies. Interactions between the sensor and a biological marker present in the sample trigger a color change that acts as a visual cue, indicating a positive or negative result. 

The difference with Mologic’s platform is that it’s exceptionally sensitive, low-cost, has a clear visual readout and can potentially be applied to many infectious diseases, for which diagnosis is at present, a complicated affair.

The strategy of this collaboration is to amplify these diagnostic capabilities by coupling them with INSPECTR™, Sherlock’s synthetic DNA biosensor platform. INSPECTR™ (an acronym for Internal Splint-Pairing Expression Cassette Translation Reaction) is the result of research performed by Sherlock’s co-founders at Harvard University. Biosensors in INSPECTR™ can detect minute amounts of a target nucleic acid sequence in blood, saliva or urine. This drives the production of a reporter protein, which can be tailored to create a signature visual signal - a colored indicator or a fluorescent glow, for example.

Speaking on the significance of this development, co-founder, CEO and President of Sherlock, Rahul K. Dhanda said, “This program will enable us to build on the power of our INSPECTR platform to create diagnostic tools that provide accurate and affordable results in virtually any setting, while working with Mologic and the Bill & Melinda Gates Foundation to develop lateral flow technology to improve global health.”

Sources: Technology Networks, Sherlock Biosciences

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and over. Managing their condition with...
MAR 07, 2020
Genetics & Genomics
MAR 07, 2020
Learning Why Men Tend to Die Younger
Data has shown conclusively that even though women tend to have poorer health than men during their adult lives, they live longer than men....
MAR 09, 2020
Cell & Molecular Biology
MAR 09, 2020
Scientists 3D Bioprint Tumor Models and Vasculature
Researchers have made numerous advances in bioengineering, bioprinting, and nanolithography....
MAR 12, 2020
Cannabis Sciences
MAR 12, 2020
In New Jersey, Medical Marijuana Patients Can't Be Fired for Drug Tests
Thirty-three states, Washington D.C., Guam, Puerto Rico and the U.S. Virgin Islands now have a comprehensive, publicly available medical marijuana program....
APR 01, 2020
Immunology
APR 01, 2020
New Airway-Hugging Immune Cells Discovered in the Lung
  Scientists have discovered a previously unknown subset of immune cells residing in the lung that specifically combat viral infections. The respirato...
APR 01, 2020
Clinical & Molecular DX
APR 01, 2020
One dollar kit diagnoses COVID-19 in 10 minutes
Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 infection in just 10 minutes. In th...
Loading Comments...